![Paulo S. Rangel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paulo S. Rangel active positions
Companies | Position | Start | End |
---|---|---|---|
Primmune Therapeutics, Inc.
![]() Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Director/Board Member | 2017-09-30 | - |
Founder | 2017-09-30 | - | |
Corporate Officer/Principal | 2017-09-30 | - |
Career history of Paulo S. Rangel
Statistics
International
United States | 2 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Primmune Therapeutics, Inc.
![]() Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Paulo S. Rangel
- Experience